Antiviral to Be Discontinued

A drug company has made a business decision to discontinue manufacturing an antiviral medication.

Mylan Pharmaceuticals has decided to discontinue manufacturing didanosine delayed-release capsules, USP, which is used to treat HIV.

The company noted that the decision had nothing to do with safety or efficacy concerns.

The following presentations are being discontinued.

Click here to read the full report.

Click here to read more about recent developments in the treatment of HIV.

--Stephanie Vaccaro

Reference:

1. U.S. Food and Drug Administration. FDA drug shortages. www.fda.gov. Accessed March 15, 2016.